-
Nillessen claims shock European 1,500m gold
-
Lala, now a hurricane, dumps heavy rain on Hawaii
-
Taylor scores two tries in winning debut as New Zealand captain
-
American Kate Douglass reclaims 50m freestyle world record
-
England defender Spence leaves Spurs for Inter Milan
-
Kit confusion disrupts Newcastle friendly against Leverkusen
-
Moore double leads Spurs to 3-0 friendly win over Hoffenheim
-
Marchand wins first Euros gold as Liebmann breaks 1500m free world record
-
Man Utd beaten by former boss Amorim's AC Milan in friendly finale
-
Zambia's vote marred by intimidation, counting pause: observers
-
Villagers evacuate as Belgium battles record wildfire
-
Marchand wins 200m butterfly for first Euros gold
-
Despite booming economy, young Moroccans still dream of Europe
-
Fernandez booed by Chelsea fans in friendly win over Sociedad
-
South Korea president proposes talks with North to formally end Korean War
-
Fans line Welsh streets as Bonnie Tyler body's returns for funeral
-
Residents evacuate as Belgium wildfire scorches 1,600 hectares
-
Tropical Storm Lala lashes Hawaii with heavy rain
-
easyJet strike sees 100 French flights cancelled
-
Lebanon reports 11 dead in strikes that Israel says targeted Hezbollah
-
Monica Bellucci and Florin Serban win at Locarno Film Festival
-
Crystal Palace sign Israel winger Khalaili
-
India's Padikkal hits unbeaten century in first Sri Lanka Test
-
Rescuers search for survivors as Indonesian quake death toll rises to 47
-
Liechtenstein places gender equality on its throne
-
Taliban govt supporters dance, take selfies in Kabul celebrations
-
Street rallies held as Taliban govt marks five years ruling Afghanistan
-
UK PM urges 'reflection' after Cambridge professor's death
-
World Cup winner Ferran Torres signs for PSG from Barcelona
-
Rescuers search for survivors as Indonesian quake death toll rises to 40
-
Monsoon rains submerge villages, fields in Myanmar
-
Earthquake rocks Spain's tourist jewel Granada
-
India's Padikkal, Rahul hit half-centuries in Sri Lanka Test
-
Perez, Fiorini set world records in winning Euro race walk golds
-
UK-based Afghan writer pleads for country's 'abandoned' women
-
Lebanon says 9 dead in strikes as Israel says targeted Hezbollah
-
Werro edges Hodgkinson in boost for world record-seeking 800m rivalry
-
World Cup winner Ferran Torres signs for Paris Saint-Germain
-
Mehidy claims Smith as Bangladesh sense historic upset in Australia
-
Disney reveals 'X-Men' cast, slate of sequels at D23 fan event
-
Indonesia rescuers search for survivors as quake death toll rises to 38
-
Star Cameroon goalkeeper Bihina faces Malawi's prolific Chawinga sisters in WAFCON final
-
Japan coach Jones says team should not get despondent after heavy loss
-
Mehidy claims Smith to keep Bangladesh on top in Australia Test
-
Flags, music as Taliban authorities mark five years ruling Afghanistan
-
Iran fires back at Trump's threat to declare Hormuz a US territory
-
'Like we were on a trampoline': Indonesia quake kills 20, thousands flee
-
No monkey business: India 'whisperers' guard world championships
-
Australia run riot to crush Japan 56-17 in Townsville
-
Steady India 101-1 at lunch in first Sri Lanka Test
Science of sleep: Why a good night's rest gets harder with age
It's well known that getting a good night's sleep becomes more difficult as we age, but the underlying biology for why this happens has remained poorly understood.
A team of US scientists has now identified how the brain circuitry involved in regulating sleepfulness and wakefulness degrades over time in mice, which they say paves the way for better medicines in humans.
"More than half of people 65 and older complain about the quality of sleep," Stanford University professor Luis de Lecea, who co-authored a study about the finding published Thursday in Science, told AFP.
Research has shown that sleep deprivation is linked to an increased risk of multiple poor health outcomes, from hypertension to heart attacks, diabetes, depression and a build up of brain plaque linked to Alzheimer's.
Insomnia is often treated with a class of drugs known as hypnotics, which include Ambien, but these don't work very well in the elderly population.
For the new study, de Lecea and colleagues decided to investigate hypocretins, key brain chemicals that are generated only by a small cluster of neurons in the brain's hypothalamus, a region located between the eyes and ears.
Of the billions of neurons in the brain, only around 50,000 produce hypocretins.
In 1998, de Lecea and other scientists discovered that hypocretins transmit signals that play a vital role in stabilizing wakefulness.
Since many species experience fragmented sleep as they grow old, it's hypothesized that the same mechanisms are at play across mammals, and prior research had shown degradation of hypocretins leads to narcolepsy in humans, dogs and mice.
The team selected young (three to five months) and old mice (18 to 22 months) and used light carried by fibers to stimulate specific neurons. They recorded the results using imaging techniques.
What they found was that the older mice had lost approximately 38 percent of hypocretins compared to younger mice.
They also discovered that the hypocretins that remained in the older mice were more excitable and easily triggered, making the animals more prone to waking up.
This might be because of the deterioration over time of "potassium channels," which are biological on-off switches critical to the functions of many types of cells.
"The neurons tend to be more active and fire more, and if they fire more, you wake up more frequently," said de Lecea.
Identifying the specific pathway responsible for sleep loss could lead to better drugs, argued Laura Jacobson and Daniel Hoyer, of Australia's Florey Institute of Neuroscience and Mental Health, in a related commentary article.
Current treatments, such as hypnotics, "can induce cognitive complaints and falls," and medicines that target the specific channel might work better, they said.
These will need to be tested in clinical trials -- but an existing drug known as retigabine, which is currently used to treat epilepsy and which targets a similar pathway -- could be promising, said de Lecea.
M.A.Colin--AMWN